LA JOLLA, Calif., Feb. 26 /PRNewswire/ -- TorreyPines Therapeutics, Inc. today announced that Dr. Neil Kurtz, President and Chief Executive Officer of TorreyPines, will present at Susquehanna Financial Group's Second Annual SIGnificant Options in Healthcare Conference in New York City on Tuesday, March 4th at 11:00 a.m., Eastern.
A webcast of Dr. Kurtz's presentation will be available live. You can access the webcast at: http://www.torreypinestherapeutics.com/. An archived version of the remarks will also be available through the Company's web site for a limited time following the conference.
About TorreyPines Therapeutics
TorreyPines Therapeutics, Inc. is a clinical-stage biopharmaceutical company committed to the discovery, development and commercialization of small molecules. The company is developing versatile product candidates, each potentially capable of treating a number of different diseases and disorders, including chronic pain, muscle spasticity and rigidity, cognitive disorders and xerostomia, or dry mouth. Further information is available at http://www.torreypinestherapeutics.com/.
Company Contact: Media Contact:
Craig Johnson David Schull
TorreyPines Therapeutics, Inc. Russo Partners, LLC
858-623-5665, x158 212-845-4271
cjohnson@torreypinestherapeutics.com david.schull@russopartnersllc.com
Investor Contact: Investor Contact:
Rhonda Chiger John Baldissera
Rx Communications BPC Financial
917-322-2569 Marketing
rchiger@rxir.com 800-368-1217
TorreyPines Therapeutics, Inc.
